US Drug Recall Register

FDA Drug Recalls

220 recalls · Class I, newest first

Class I · High risk Ongoing

GoHARD 25000

Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Pyramids Wholesale Inc. D-0453-2024
Class I · High risk Ongoing

Pink Pussycat Honey

Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Pyramids Wholesale Inc. D-0452-2024
Class I · High risk Ongoing

Samurai-X Honey 6800

Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Pyramids Wholesale Inc. D-0451-2024
Class I · High risk Ongoing

Flower Power

Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Pyramids Wholesale Inc. D-0450-2024
Class I · High risk Ongoing

Weiner Boner Honey

Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Pyramids Wholesale Inc. D-0449-2024
Class I · High risk Ongoing

Spanish Fly 22K capsules

Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Pyramids Wholesale Inc. D-0448-2024
Class I · High risk Ongoing

Treprostinil Injection

Reason Presence of Particulate Matter.

Par Sterile Products LLC D-0429-2024
Class I · High risk Ongoing

Methocarbamol Injection

Reason Presence of Particulate Matter

Eugia US LLC NDC 55150-223-10 D-0440-2024
Class I · High risk Ongoing

Arize Herbal Dietary Supplement

Reason Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared nortadalafil, an ingredient found in FDA approved product for the treatment of male sexual enhancement, making this drug an unapproved drug.

Today The World D-0345-2024
Class I · High risk Ongoing

SCHWINNNG Herbal Dietary Supplement

Reason Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared nortadalafil, an ingredient found in FDA approved product for the treatment of male sexual enhancement, making this drug an unapproved drug.

Today The World D-0344-2024
Class I · High risk Ongoing

Sustain Herbal Dietary Supplement

Reason Marketed Without An Approved NDA/ANDA: FDA analysis found this product to be tainted with undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this drug an unapproved drug.

Today The World D-0343-2024
Class I · High risk Ongoing

To the Moon Capsules

Reason Marketed Without an Approved NDA/ANDA: Products contain undeclared sildenafil.

Integrity Products D-0586-2024
Class I · High risk Ongoing

Ram It

Reason Marketed Without an Approved NDA/ANDA: Products contain undeclared sildenafil.

Integrity Products D-0585-2024
Class I · High risk Ongoing

Neptune's Fix

Reason Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.

Neptune Resources, LLC D-0335-2024
Class I · High risk Ongoing

Neptune's Fix

Reason Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.

Neptune Resources, LLC D-0334-2024
Class I · High risk Ongoing

Neptune's Fix

Reason Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.

Neptune Resources, LLC D-0333-2024
Class I · High risk Ongoing

PHENYLephrine HCl 40 mg per 250 mL 0.9% Sodium Chloride

Reason Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.

Denver Solutions, LLC DBA Leiters Health NDC 71449-150-82 D-0280-2024
Class I · High risk Ongoing

PHENYLephrine HCl 20 mg per 250 mL 0.9% Sodium Chloride

Reason Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.

Denver Solutions, LLC DBA Leiters Health NDC 71449-148-94 D-0279-2024
Class I · High risk Ongoing

FentaNYL citrate PF

Reason Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.

Denver Solutions, LLC DBA Leiters Health NDC 71449-072-82 D-0278-2024
Class I · High risk Ongoing

FentaNYL citrate PF

Reason Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.

Denver Solutions, LLC DBA Leiters Health NDC 71449-072-41 D-0277-2024
Class I · High risk Ongoing

Bleomycin for Injection

Reason Presence of particulate matter: glass

Pfizer NDC 61703-332-18 D-0261-2024